{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:05:27Z","timestamp":1779426327050,"version":"3.53.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171768"],"award-info":[{"award-number":["82171768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Young Talents in medical and health care under the Special Support Program for High-level Talents in Zhejiang Province, the National Key Research and Development Program of China","award":["2022YFC3602000"],"award-info":[{"award-number":["2022YFC3602000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00259-026-07900-8","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:56:41Z","timestamp":1776902201000},"page":"4757-4767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Superior correlation with clinical activity and unique detection patterns: a prospective study of FAPI versus FDG-PET in polymyalgia rheumatica and giant cell arteritis"],"prefix":"10.1007","volume":"53","author":[{"given":"Xinxin","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiduo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-7841","authenticated-orcid":false,"given":"Weiqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"7900_CR1","doi-asserted-by":"publisher","unstructured":"Dejaco C et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015;74(10):1799\u2009\u2013\u2009807. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207492.","DOI":"10.1136\/annrheumdis-2015-207492"},{"key":"7900_CR2","doi-asserted-by":"publisher","unstructured":"Hellmich B et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79(1):19-30. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215672.","DOI":"10.1136\/annrheumdis-2019-215672"},{"key":"7900_CR3","doi-asserted-by":"publisher","unstructured":"Dasgupta B et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71(4):484\u2009\u2013\u200992. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200329.","DOI":"10.1136\/annrheumdis-2011-200329"},{"issue":"12","key":"7900_CR4","doi-asserted-by":"publisher","first-page":"p1647","DOI":"10.1136\/ard-2022-223480","volume":"81","author":"C Ponte","year":"2022","unstructured":"Ponte C, et al. 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022;81(12):p1647\u20131653. https:\/\/doi.org\/10.1136\/ard-2022-223480.","journal-title":"Ann Rheum Dis"},{"key":"7900_CR5","doi-asserted-by":"publisher","unstructured":"van der Geest KSM et al. Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2021;48(6):1876-1889. https:\/\/doi.org\/10.1007\/s00259-020-05162-6.","DOI":"10.1007\/s00259-020-05162-6"},{"key":"7900_CR6","doi-asserted-by":"publisher","first-page":"p69","DOI":"10.1016\/j.ejim.2024.03.037","volume":"126","author":"AC Billet","year":"2024","unstructured":"Billet AC, et al. Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective study. Eur J Intern Med. 2024;126:p69\u201376. https:\/\/doi.org\/10.1016\/j.ejim.2024.03.037.","journal-title":"Eur J Intern Med"},{"issue":"7","key":"7900_CR7","doi-asserted-by":"publisher","first-page":"p1250","DOI":"10.1007\/s00259-018-3973-8","volume":"45","author":"R Slart","year":"2018","unstructured":"Slart R. FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45(7):p1250\u20131269. https:\/\/doi.org\/10.1007\/s00259-018-3973-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"7900_CR8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, et al. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. J Nucl Med. 2018;59(9):1415\u201322. https:\/\/doi.org\/10.2967\/jnumed.118.210443.","journal-title":"J Nucl Med"},{"issue":"6","key":"7900_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, et al. (68)Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med. 2019;60(6):801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"issue":"5","key":"7900_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1053\/j.semnuclmed.2023.02.001","volume":"53","author":"M Bentestuen","year":"2023","unstructured":"Bentestuen M, Al-Obaydi N, Zacho HD. FAPI-avid nonmalignant PET\/CT findings: An expedited systematic review. Semin Nucl Med. 2023;53(5):694\u2013705. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.02.001.","journal-title":"Semin Nucl Med"},{"issue":"10","key":"7900_CR11","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/ard.2003.011379","volume":"63","author":"BF Leeb","year":"2004","unstructured":"Leeb BF, Bird HA. A disease activity score for polymyalgia rheumatica. Ann Rheum Dis. 2004;63(10):1279\u201383. https:\/\/doi.org\/10.1136\/ard.2003.011379.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7900_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3899\/jrheum.110977","volume":"39","author":"EL Matteson","year":"2012","unstructured":"Matteson EL, et al. Patient-reported outcomes in polymyalgia rheumatica. J Rheumatol. 2012;39(4):795\u2013803. https:\/\/doi.org\/10.3899\/jrheum.110977.","journal-title":"J Rheumatol"},{"issue":"13","key":"7900_CR13","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s00259-020-04871-2","volume":"47","author":"F Kang","year":"2020","unstructured":"Kang F, et al. Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu\u2019s arteritis patients. Eur J Nucl Med Mol Imaging. 2020;47(13):3107\u201317. https:\/\/doi.org\/10.1007\/s00259-020-04871-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"7900_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11604-020-01059-4","volume":"39","author":"U Tateishi","year":"2021","unstructured":"Tateishi U, Tsuchiya J, Yokoyama K. Large vessel vasculitis: imaging standards of (18)F-FDG PET\/CT. Jpn J Radiol. 2021;39(3):225\u201332. https:\/\/doi.org\/10.1007\/s11604-020-01059-4.","journal-title":"Jpn J Radiol"},{"issue":"4","key":"7900_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.semnuclmed.2004.06.006","volume":"34","author":"G El-Haddad","year":"2004","unstructured":"El-Haddad G, et al. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med. 2004;34(4):313\u201329. https:\/\/doi.org\/10.1053\/j.semnuclmed.2004.06.006.","journal-title":"Semin Nucl Med"},{"key":"7900_CR16","doi-asserted-by":"publisher","unstructured":"Mori Y et al. FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease. Radiology. 2023;306(2):e220749. https:\/\/doi.org\/10.1148\/radiol.220749.","DOI":"10.1148\/radiol.220749"},{"issue":"1","key":"7900_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1056\/NEJMcp1214825","volume":"371","author":"CM Weyand","year":"2014","unstructured":"Weyand CM, Goronzy JJ. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014;371(1):50\u20137. https:\/\/doi.org\/10.1056\/NEJMcp1214825.","journal-title":"N Engl J Med"},{"issue":"6","key":"7900_CR18","doi-asserted-by":"publisher","first-page":"pe1004249","DOI":"10.1371\/journal.pmed.1004249","volume":"20","author":"X Ma","year":"2023","unstructured":"Ma X, et al. Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial. PLoS Med. 2023;20(6):pe1004249. https:\/\/doi.org\/10.1371\/journal.pmed.1004249.","journal-title":"PLoS Med"},{"issue":"5","key":"7900_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","volume":"77","author":"C Dejaco","year":"2018","unstructured":"Dejaco C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636\u201343. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212649.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7900_CR20","doi-asserted-by":"publisher","first-page":"p101822","DOI":"10.1016\/j.berh.2023.101822","volume":"36","author":"M Man-Ger Sun","year":"2022","unstructured":"Man-Ger Sun M, Pope JE. Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis. Best Pract Res Clin Rheumatol. 2022;36(4):p101822. https:\/\/doi.org\/10.1016\/j.berh.2023.101822.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"7900_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00259-023-06459-y","volume":"51","author":"HSA Tingen","year":"2024","unstructured":"Tingen H.S.A., et al. Cardiac [(99m)Tc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker? Eur J Nucl Med Mol Imaging. 2024;51(3):681\u201390. https:\/\/doi.org\/10.1007\/s00259-023-06459-y.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07900-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:08:50Z","timestamp":1779422930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07900-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7900"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07900-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of The First Affiliated Hospital, Zhejiang University School of Medicine (Approval Number: IIT20200070C-R1). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}